SCHEDULE 13G

Company

Merck & Co., Inc.

Filed

February 2, 2022

Accession Number

0001104659-22-010933

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →